ArticleScientific reports2022

Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action.

Jozafina Milicaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.